These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35819894)

  • 1. Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience.
    Martinelli AW; Wright CB; Lopes MS; Swayne RL; Krishnamurthy P; Crawley C; Uttenthal B; Follows G; Babar J; Aliyu SH; Enoch DA; Sander CR
    J Med Microbiol; 2022 Jul; 71(7):. PubMed ID: 35819894
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment.
    Martinelli AW; Patil P; Wong VK; Enoch DA; Sander CR
    J Med Microbiol; 2019 Dec; 68(12):1766-1770. PubMed ID: 31746725
    [No Abstract]   [Full Text] [Related]  

  • 4. Empirical antifungal treatment for diagnosed and undiagnosed invasive fungal disease in patients with hematologic malignancies.
    Deng Q; Lv HR; Lin XM; Zhao MF; Geng L; Li YM
    Curr Med Res Opin; 2018 Jul; 34(7):1209-1216. PubMed ID: 28956459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers (the 6th revision)].
    ;
    Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):754-763. PubMed ID: 32987477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
    Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
    Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of the EORTC/MSG criteria for IFD in clinical practice.
    Rieger H; Lustig D; Barlow S; Ostermann H; Fiegl M; Peterson L; Rieger CT
    Ann Hematol; 2015 May; 94(5):847-55. PubMed ID: 25544029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
    Ruhnke M; Cornely OA; Schmidt-Hieber M; Alakel N; Boell B; Buchheidt D; Christopeit M; Hasenkamp J; Heinz WJ; Hentrich M; Karthaus M; Koldehoff M; Maschmeyer G; Panse J; Penack O; Schleicher J; Teschner D; Ullmann AJ; Vehreschild M; von Lilienfeld-Toal M; Weissinger F; Schwartz S
    Mycoses; 2020 Jul; 63(7):653-682. PubMed ID: 32236989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.
    Takagi S; Araoka H; Uchida N; Uchida Y; Kaji D; Ota H; Nishida A; Ishiwata K; Tsuji M; Yamamoto H; Ito T; Matsuno N; Yamamoto G; Asano-Mori Y; Hayashi M; Izutsu K; Masuoka K; Wake A; Makino S; Yoneyama A; Taniguchi S
    Int J Hematol; 2014; 99(5):652-8. PubMed ID: 24664791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triggers for driving treatment of at-risk patients with invasive fungal disease.
    Drgona L; Colita A; Klimko N; Rahav G; Ozcan MA; Donnelly JP
    J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii17-iii24. PubMed ID: 24155142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
    Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D
    Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Antifungal Prescribing Patterns Identify Significant Opportunities to Rationalize Antifungal Use in Children.
    Ferreras-Antolín L; Irwin A; Atra A; Chapelle F; Drysdale SB; Emonts M; McMaster P; Paulus S; Patel S; Rompola M; Vergnano S; Whittaker E; Warris A
    Pediatr Infect Dis J; 2022 Mar; 41(3):e69-e74. PubMed ID: 34784303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
    Lum L; Lee A; Vu M; Strasser S; Davis R
    Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.
    Donnelly JP; Chen SC; Kauffman CA; Steinbach WJ; Baddley JW; Verweij PE; Clancy CJ; Wingard JR; Lockhart SR; Groll AH; Sorrell TC; Bassetti M; Akan H; Alexander BD; Andes D; Azoulay E; Bialek R; Bradsher RW; Bretagne S; Calandra T; Caliendo AM; Castagnola E; Cruciani M; Cuenca-Estrella M; Decker CF; Desai SR; Fisher B; Harrison T; Heussel CP; Jensen HE; Kibbler CC; Kontoyiannis DP; Kullberg BJ; Lagrou K; Lamoth F; Lehrnbecher T; Loeffler J; Lortholary O; Maertens J; Marchetti O; Marr KA; Masur H; Meis JF; Morrisey CO; Nucci M; Ostrosky-Zeichner L; Pagano L; Patterson TF; Perfect JR; Racil Z; Roilides E; Ruhnke M; Prokop CS; Shoham S; Slavin MA; Stevens DA; Thompson GR; Vazquez JA; Viscoli C; Walsh TJ; Warris A; Wheat LJ; White PL; Zaoutis TE; Pappas PG
    Clin Infect Dis; 2020 Sep; 71(6):1367-1376. PubMed ID: 31802125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
    Lortholary O; Fernández-Ruiz M; Perfect JR
    J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease.
    Armstrong AE; Rossoff J; Hollemon D; Hong DK; Muller WJ; Chaudhury S
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27734. PubMed ID: 30941906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience.
    Castagnola E; Bagnasco F; Amoroso L; Caviglia I; Caruso S; Faraci M; Calvillo M; Moroni C; Bandettini R; Cangemi G; Magnano GM; Buffa P; Moscatelli A; Haupt R
    Pediatr Infect Dis J; 2014 Mar; 33(3):233-7. PubMed ID: 24136371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive Fungal Disease in Pediatric Solid Organ Transplant Recipients.
    Saxena S; Gee J; Klieger S; Kajon A; Petersen H; Zaoutis T; Fisher B
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):219-225. PubMed ID: 28992290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.